Arjo AB Class B ( (ARRJF) ) has released its Q1 earnings. Here is a breakdown of the information Arjo AB Class B presented to its investors.
Arjo AB Class B is a prominent company in the healthcare sector, specializing in medical devices and solutions aimed at improving patient care and mobility. The company operates globally, with a strong presence in North America and Europe, and is known for its innovative products and commitment to sustainability.
In its latest earnings report for the first quarter of 2025, Arjo AB reported a modest increase in net sales, reaching SEK 2,863 million, marking an organic growth of 3.4%. The company also launched the new Maxi Move 5 mobile patient floor lift, which has been well-received in key markets.
Key financial metrics indicate a mixed performance, with an improved gross margin of 43.7% and a strengthened order book. However, adjusted EBITDA decreased to SEK 486 million from SEK 502 million in the previous year, and profit after financial items fell to SEK 125 million from SEK 175 million. The company faced challenges from currency effects, impacting its profitability.
Despite these challenges, Arjo remains optimistic about its growth prospects for 2025, expecting organic sales growth within its target range of 3-5%. The company is focused on enhancing its long-term competitiveness through new product launches and cost-efficiency initiatives.
Looking ahead, Arjo’s management is confident in navigating the uncertain macroeconomic environment, emphasizing its strong market positions and broad product portfolio to drive sustainable growth.